Prospective, Single-blind Study Assessing the Benefit/Risk Ratio of Internal Limiting Membrane (ILM) Peeling During Epimacular Membrane (EMM) Surgery (Peeling)

NACompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

September 9, 2014

Primary Completion Date

March 14, 2022

Study Completion Date

March 14, 2022

Conditions
Idiopathic Epimacular Membrane
Interventions
PROCEDURE

ILM Peeling

"common surgical procedure:~For phakic eyes with cataract • phacoemulsification and implantation of a posterior chamber intraocular lens~For all patients:~* Central and peripheral 25 Gauge vitrectomy~* dissection of the epimacular membrane~* injection of Membraneblue-Dual® according to protocol, wait of 1 minute with the infusion line closed, and then suction of surplus and washing of the vitreous cavity~* Intraoperative picture to see the possible spontaneous ILM peeling~* If no spontaneous ILM peeling, the patient will be randomized at the operating block~Specific surgical procedure:~• • Randomization into two groups:~* Arm 1: no peeling, where the ILM peeling will not be made~* Arm 2: active peeling, where the ILM peeling will be made"

Trial Locations (6)

44000

Clinique Sourdille, Nantes

44800

Polyclinique de l'atlantique, Saint-Herblain

Unknown

CHU de Dijon, Dijon

CHU de Nantes, Nantes

Fondation Ophtalmologique A. de Rothschild, Paris

Hôpital Lariboisière (AP-HP), Paris

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT02146144 - Prospective, Single-blind Study Assessing the Benefit/Risk Ratio of Internal Limiting Membrane (ILM) Peeling During Epimacular Membrane (EMM) Surgery (Peeling) | Biotech Hunter | Biotech Hunter